Lineage Cell Therapeutics (LCTX.TA) Q2 2024 Earnings

May 9Confirmed
Q4 2023
Q2 2024
-14.91
-9.95
-4.99
-0.03

Details

Expected EPS
-14.289699074
Actual EPS
-14.91112
Surprise EPS
-0.62
Surprise Percent
-4.35%

Description

⁨Lineage Cell Therapeutics⁩ (⁦LCTX.TA⁩) has reported earnings of ⁦-14.91112⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts